News
Psilocybin Could Become the First FDA-Approved Psychedelic Therapy Within Months — Here Is What Patients Need to Know
Psilocybin could receive FDA approval by late 2026 following a Trump executive order and priority review vouchers. Here's what the evidence shows and what it means for patients.
→
Beyond Glucosamine: What Three Published Human Trials Show Clinicians About Cartilage Regeneration Support
The peer-reviewed research on cartilage regeneration has evolved. Here is what the published data on Cartigenix HP® with RestorCel™ shows, and how it differs from the clinical evidence for conventional joint supplements.
→
A Parasite Has Sickened 145 People in 17 States as Investigators Search for the Source
145 Cyclospora cases in 17 states, no source identified yet. Summer is peak season for this parasite linked to leafy greens. Here's what to watch for and when to ask for specific testing.
→
